Denis Chem Lab Ltd
Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]
- Market Cap ₹ 91.3 Cr.
- Current Price ₹ 65.8
- High / Low ₹ 98.9 / 56.1
- Stock P/E 11.4
- Book Value ₹ 66.0
- Dividend Yield 3.80 %
- ROCE 14.0 %
- ROE 9.52 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
- Stock is providing a good dividend yield of 3.80%.
- Company has been maintaining a healthy dividend payout of 32.7%
Cons
- The company has delivered a poor sales growth of 10.8% over past five years.
- Promoter holding is low: 39.0%
- Company has a low return on equity of 11.2% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75 | 98 | 112 | 107 | 123 | 135 | 109 | 136 | 161 | 167 | 173 | 181 | 182 | |
| 66 | 89 | 98 | 95 | 110 | 120 | 99 | 122 | 142 | 146 | 157 | 164 | 166 | |
| Operating Profit | 9 | 8 | 14 | 12 | 14 | 15 | 10 | 14 | 19 | 21 | 16 | 18 | 17 |
| OPM % | 12% | 9% | 12% | 11% | 11% | 11% | 9% | 11% | 12% | 13% | 9% | 10% | 9% |
| 0 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | |
| Interest | 5 | 7 | 6 | 5 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 6 | 7 | 6 | 6 | 7 | 6 | 6 | 8 | 7 | 7 | 7 | 7 |
| Profit before tax | 0 | -3 | 2 | 2 | 6 | 6 | 3 | 9 | 11 | 15 | 11 | 12 | 11 |
| Tax % | 78% | 30% | 37% | -5% | -7% | 26% | 27% | 30% | 28% | 26% | 27% | 29% | |
| 0 | -4 | 1 | 2 | 6 | 4 | 2 | 6 | 8 | 11 | 8 | 8 | 8 | |
| EPS in Rs | 0.07 | -4.16 | 0.89 | 1.54 | 4.58 | 3.03 | 1.63 | 4.51 | 5.66 | 8.04 | 5.82 | 6.06 | 5.75 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 22% | 0% | 46% | 33% | 35% | 31% | 26% | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 11% |
| 3 Years: | 4% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 30% |
| 3 Years: | 2% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 0% |
| 3 Years: | -14% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | 11% |
| Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 12 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 8 | 7 | 18 | 36 | 43 | 45 | 48 | 53 | 58 | 66 | 71 | 78 |
| 48 | 44 | 37 | 25 | 23 | 14 | 9 | 3 | 2 | 1 | 1 | 4 | |
| 17 | 24 | 27 | 26 | 26 | 25 | 22 | 27 | 25 | 28 | 26 | 29 | |
| Total Liabilities | 81 | 85 | 94 | 101 | 106 | 97 | 92 | 96 | 99 | 109 | 112 | 125 |
| 42 | 40 | 44 | 40 | 50 | 46 | 41 | 42 | 35 | 38 | 39 | 37 | |
| CWIP | 0 | 10 | 1 | 5 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 39 | 35 | 49 | 56 | 55 | 52 | 51 | 55 | 62 | 72 | 73 | 88 | |
| Total Assets | 81 | 85 | 94 | 101 | 106 | 97 | 92 | 96 | 99 | 109 | 112 | 125 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | 21 | 7 | 11 | 8 | 13 | 8 | 17 | 16 | 18 | 12 | 4 | |
| -28 | -13 | -1 | -16 | -2 | -2 | -1 | -10 | -11 | -15 | -8 | -5 | |
| 13 | -7 | -0 | 1 | -5 | -14 | -6 | -7 | -4 | -4 | -4 | 0 | |
| Net Cash Flow | -1 | 1 | 5 | -4 | 1 | -3 | 1 | -0 | 1 | -1 | -0 | -0 |
| Free Cash Flow | -14 | 8 | 5 | 2 | -2 | 11 | 6 | 12 | 12 | 11 | 4 | -1 |
| CFO/OP | 154% | 246% | 49% | 92% | 65% | 101% | 85% | 126% | 100% | 104% | 105% | 38% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 123 | 85 | 104 | 105 | 106 | 94 | 110 | 85 | 71 | 69 | 65 | 78 |
| Inventory Days | 40 | 39 | 35 | 52 | 50 | 51 | 60 | 50 | 39 | 43 | 37 | 40 |
| Days Payable | 81 | 119 | 136 | 150 | 102 | 108 | 103 | 99 | 79 | 90 | 81 | 81 |
| Cash Conversion Cycle | 81 | 4 | 3 | 8 | 55 | 37 | 67 | 36 | 31 | 22 | 21 | 36 |
| Working Capital Days | -19 | -57 | -13 | 4 | 17 | 32 | 63 | 51 | 41 | 37 | 38 | 50 |
| ROCE % | 11% | 5% | 12% | 9% | 11% | 11% | 6% | 14% | 16% | 20% | 14% | 14% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Employees count |
|
|||||||||
| Installed Capacity - Glass Bottles crore bottles per annum |
||||||||||
| Installed Capacity - Plastic Bottles crore bottles per annum |
||||||||||
| Installed Capacity - Eurohead Bottles crore bottles per annum |
||||||||||
| Number of Licensed Products count |
||||||||||
| Capacity Utilization % |
||||||||||
Extracted by Screener AI
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We are enclosing herewith Clipping of Newspaper advertisement for 45th Annual General Meeting of the Company Published on 20th August, 2026.
-
Announcement Under Regulation 30 (LODR) - Notice Of 45Th AGM Along With Annual Report 2025-26
- 45th AGM on 25 Sep 2026; Rs 2.50 final dividend proposed, MD reappointment included.
- Shareholders Meeting - Submission Of Notice Of 45Th AGM Of The Company Along With Annual Report 2025-26
-
Reg. 34 (1) Annual Report.
- 45th AGM on 25 Sep 2026; final dividend Rs.2.50/share; MD reappointment for 3 years.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
DCLL manufactures and markets sterile Intravenous injectibles in Glass and Plastic Bottles for human and veterinary consumption. It also manufactures products on contract basis for multinational pharmaceutical companies who market them under their own brands. Company has a fully equipped in-house Quality Control Laboratory having different interdepartments for Chemical Testing, Physico-Chemical Testing, Microbiological Testing, Pyrogens Testing, Sterility Testing and Toxicity Testing. All raw materials, packaging materials, in process testing and finished stocks are tested in-house.